The bone marrow (BM) is home to different stem/progenitor populations, including tissue-committed stem cells. In this context, we have cocultured BM-derived stem cells (BMSC) in order to investigate their differentiation capacity towards the retinal pigment epithelial (RPE) lineage in vitro. Furthermore, pre-differentiated BMSC were transplanted into the pharmacologically damaged subretinal space to determine their rescue ability in vivo. BM was harvested from the tibias and femurs of adult GFP + C57BL/6 mice. Differentiated hematopoietic cells were removed by lineage depletion, and CD45 -BMSCs were separated by magnetic activated cell sorting (MACS). To induce differentiation, the cells were then cocultured with murine RPE for 10 days, and retinal markers were assessed using immunohistochemistry (IHC). To induce retinal degeneration, mice were treated with sodium iodate (NaIO 3 ). Seven days later, approx. 60,000 pre-differentiated GFP + BMSC, sorted by FACS, were transplanted subretinally. Optical coherence tomography (OCT) was used to follow the transplants and to quantify the retinal thickness over time. Visual acuity was measured concurrently using the optokinetic reflex (OKR). Finally, IHC was performed to investigate the expression of retina-specific markers in the transplants. CD45 -BMSC adopted an RPE-like elongated morphology and showed expression of the RPE markers RPE65 and bestrophin after coculture. After transplantation of CD45 -BMSC, visual acuity increased in individual animals compared to the contralateral control eye, but did not reach baseline levels. Additionally, no significant increase in retinal thickness in the transplanted eye was found. However, the cells were detectable in the subretinal space for up to 28 days and expressed the RPE markers RPE65 and bestrophin. In summary, the BMSC differentiated into RPE-like cells but were not able to restore visual function or rescue retinal morphology after subretinal transplantation.
Introduction
Replacement of the degenerated retinal pigment epithelium (RPE) before irreversible degeneration of the foveal photoreceptors occurs was considered as a potential therapy for age-related macular degeneration (AMD) nearly 20 years ago [1] . However, several experimental and clinical trials since then have shown that allogeneic RPE cells were not able to attach and fail to fill in the atrophic area under pathological conditions [2, 3] . Autologous RPE cell transplantation did also not show evidence of functional recovery [4, 5] . In order to achieve more effective regeneration of the damaged retinal structures stem cells (SC) have come into the focus.
New findings have recently contradicted the central dogmas of commitment of adult SC, including bone marrow-derived stem cells (BMSCs), by showing their plasticity to differentiate across tissue-lineage boundaries, irrespective of classical germ layer designations [6] . In this context transdifferentiation into non-hematopoietic, including retinal, cell types was documented [7] [8] [9] . The bone marrow contains several subsets of SCs including hematopoietic stem cells providing all blood cell types, non-hematopoietic mesenchymal stem cells that differentiate into mesenchymal tissue and a population of tissue-committed SCs. The existence of these already committed SCs has increased research in the differentiation capacity of adult BMSCs for autologous regeneration purposes [10] . Indeed, a subset of Lin -Sca-1 + CD45 -BMSCs that express markers of ocular (retina/RPE) progenitors have been identified and isolated [11] . Furthermore, BMSCs can be triggered to commit to and progress along the RPE differentiation pathway in culture [12] . BMSCs also home to the subretinal space if systemically transferred or endogenously mobilized where they express RPE lineage markers [13] [14] [15] .
Pre-differentiation of SC in vitro using extrinsic factors and/or coculturing is thereby a possible way not only to commit the cells towards a distinctive fate but also to enhance their properties and possibly the outcome of regenerative approaches [16, 17] . Therefore, we have investigated the potential of Lin -CD45 -BMSCs to be pre-committed towards the RPE lineage in vitro and to morphologically and functionally regenerate damaged retinal tissue after subretinal transplantation. To quantify potential rescue effects in vivo, we have used the sodium iodate (NaIO 3 ) model of retinal degeneration [18] . NaIO 3 is specifically toxic for the RPE, triggering damage to photoreceptors and the choriocapillaris in a dose-and time-dependent manner [19, 20] . The deleterious effects of NaIO 3 on the different retinal cell types can also be linked to the impairment of functional visual behavior [21] .
Herein, we present evidence that CD45 -BMSCs express RPE markers after coculture with adult RPE but cannot restore visual function completely or rebuild retinal structures that were damaged during retinal degeneration. Further investigation into the potential use of BMSCs to replace degenerated cells for the repair of degenerative changes in the retina is therefore necessary.
Materials and methods:

Cell preparation
All animal experiments were conducted according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research following governmental approval. BMSCs were obtained from 3-4-week-old GFP + mice (C57BL/6-Tg(UBC-GFP)30Scha/J, Stock Number: 4353). Full bone marrow from a minimum of eight animals was harvested from the femurs and tibias, and magnetic activated cell separation (MACS™) was used for separation according to the manufacturer's recommendations. In short, initial lineage depletion (Lineage Cell Depletion Kit, mouse; Miltenyi Biotec, Bergisch Gladbach, Germany) was performed on LS separation columns. This was followed by separation of Lin -CD45 + cells (CD45 Micro Beads, mouse; Miltenyi Biotec) on MS separation columns. Lineage-negative cells represented 1.52 ± 0.01% of the total bone marrow cell population. Further separation yielded 48.70 ± 0.18% CD45 -BMSCs of the entire lineage-negative fraction.
Murine adult RPE were enzymatically prepared from 10-day-old C57BL/6 mice. Thereby, the eyes were enucleated, washed, and incubated in dispase for 25 min at 37°C. The anterior part of the eye, lens and sensory retina was then discarded and the RPE mechanically harvested. The cells were plated in DMEM + 10% fetal calf serum + 0.1% antibiotic-antimycotic solution (Life Technologies) for long-term cell culture (maximum five passages).
Coculture of BMSC
The isolated GFP + CD45 -BMSCs were grown in coculture with RPE in 0.1% gelatin-coated culture vessels at a 1:1 ratio for up to 10 days with 35,000 cells/well in an eight-well chamber slide (Lab-Tek II; Sigma-Aldrich) or 100,000 cells/well in a six-well plate (Greiner Bio-One, Frickenhausen, Germany). To inhibit proliferation, the feeder cells were treated with mitomycin C for 20 min (50 µg/ml; Sigma-Aldrich) before coculture. Every three days, half of the differentiation medium [DMEM + GlutaMAX with 10% fetal calf serum (Life Technologies), 1% cell shield (Minerva Biolabs, Berlin, Germany), and 10 µM Rock inhibitor Y-27632 (Sigma-Aldrich; for the first 3 days only)] was changed. The cocultures were then either characterized by immunohistochemistry (IHC) or separated by FACS for transplantation purposes (see below). IHC was also performed to evaluate BMSC differentiation after transplantation (see below). For this, 5-µm-thick paraffin retina sections were boiled in Tris EDTA pH 9.0 + 0.05% Tween 20 in a pressure cooker for 3 min. Nonspecific binding was blocked with 10% normal goat serum + 1% bovine serum albumin in Tris-buffered saline + 0.025% Triton 100 (Life Technologies) at pH 7.6 in a humidity chamber at RT for 2 h. The sections were then incubated with marker-specific primary antibodies at 4°C overnight (Table 1) . After washing, the sections were incubated with secondary antibodies (see above) at RT for 45 min. This was followed by consecutive staining for GFP, beginning with blocking with 3% normal mouse serum at RT for 1 h, and followed by the primary antibody [chicken anti-GFP (Abcam) 1:500] incubation at 4°C overnight. After washing, the sections were incubated with secondary antibodies [goat anti-chicken Alexa488 (Life Technologies) 1:1000] at RT for 45 min and mounted with Vectashield (Vector Labs).
Immunohistochemistry
FACS sorting
The cells were detached from six-well tissue culture plates using a non-enzymatic dissociation solution (Sigma-Aldrich) at coculture day 10. GFP + BMSCs were separated from the feeder cells by fluorescence activated cell sorting (FACS) using a BD FACSAria TM (Becton Dickinson, Mountainview, CA, USA). In order to segregate the different cell populations, the samples were gated according to their side scatter (SSC) and forward scatter (FSC) pattern using cultured RPE and bone marrow cells as controls. Propidium iodide (PI; Sigma-Aldrich) was used to exclude dead cells and the FL1 fluorescence channel to select GFP + cells. The sorting strategy has been visualized in supplemental figure S1.
Subretinal transplantation in the NaIO 3 model
Six-to eight-week-old male C57BL/6 mice (Charles River WIGA, Sulzfeld, Germany) received a single i.v. injection of sterile 0.5% sodium iodate (NaIO 3 ; Sigma-Aldrich) in saline (final concentration: 15 mg/kg body weight) or 100 µl 0.9% NaCl. In correlation with the kinetics of the NaIO 3 -induced degeneration, pre-differentiated GFP + BMSCs in balanced salt solution (BSS; Alcon; Hünenberg, Switzerland) were transplanted into the subretinal space of the right eyes 7 days after the initiation of retinal degeneration. The left eyes served as controls and received a similar volume of BSS. Before surgery, pupils were dilated by topical instillation of 2.5% phenylephrine + 0.5% tropicamide (MIX eye drops; ISPI, Bern, Switzerland), and the animals were anesthetized with 2% isoflurane (Forene; Abbott, Baar, Switzerland). Oxybuprocaine (Novesin 0.4%; OmniVision, Neuhausen, Switzerland) was used for local anesthesia. The cells were delivered to the subretinal space by a scleral approach using a Hamilton syringe with a 30-gauge RN needle (Hamilton, Bonaduz, Switzerland). The procedure was performed under sterile conditions using a surgical microscope and a coverslip on hydroxypropyl methylcellulose (Methocel 2%, OmniVision) to adjust the refractive power.
Transplant imaging and retinal thickness measurement
To visualize location and fate of the transplants over time, fundus autofluorescence (FAF) and optical coherence tomography (OCT) images were recorded on day 7, 14, 21, and 28 post transplantation (PT). For that, the animals received general anesthesia using subcutaneous injection of 80 mg/kg ketamine (Ketalar 50 mg/ml; Pfizer, Zurich, Switzerland) and 1 mg/kg medetomidine (Domitor 1 mg/ml; Orion Pharma, Espoo, Finland). Pupils were dilated with 2.5% phenylephrine + 0.5% tropicamide (MIX eye drops; ISPI). Methylcellulose (Methocel 2%; OmniVision, Neuhausen, Switzerland) in combination with a contact lens (Quantum I; Bausch + Lomb, Rochester, NY, USA) was used to effectively correct the refractive power of the aircorneal interface and to avoid corneal dehydration. A 78D double-aspheric fundus lens (Volk Optical, Inc., Mentor, OH) was used to adapt the mouse optics to the Spectralis HRA+OCT device (Heidelberg Engineering, Heidelberg, Germany). The anesthesia was revoked by atipamezole (Antisedan 5 mg/ml; Orion Pharma).
The system allows for simultaneous recording of OCT scans with infrared (IR; excitation wavelength: 513 nm) and FAF (excitation wavelength: 488 nm) images. The IR and FAF images were obtained in accordance with a standardized operation protocol, whereas the OCT imaging was performed by manually adjusting the length of the reference pathway using the "OCT debug window" to adjust for the optical length of the scanning pathway. Ring-like OCT scans with a 30° field-of-view centered at the optic nerve head (ONH) as well as horizontal OCT scans were used for the analyses of structural changes. For single scans, 25 OCT scans were averaged.
In addition, a volume cube consisting of 49 single scans centered on the optic disc was recorded with a 30° field-of-view centered on the ONH. For each scan of the volume cube, nine OCT scans were averaged. This volume scan was used to calculate a retinal thickness map across the scanned retinal area. Thereby, the four circular inner subfields at 3-mm diameter around the central field surrounding the ONH were used, whereas the central (used for alignment of the ONH) and the outer (out of range due to the curvature of the small size of the eyes) subfields were excluded.
For the overview staining at the final time point, the eyes were dehydrated, embedded in paraffin, and 5-µm-thick transverse sections were cut and stained with hematoxylin and eosin (H&E; Sigma-Aldrich).
Functional measurement
Visual function was assessed using the OptoMotry system (CerebralMechanics, Lethbridge, AB, Canada) as described previously [22] . The optokinetic reflex (OKR) was thereby measured at baseline (BL), three days after NaIO 3 injection, and on 7, 14, 21, and 28 days PT. The system comprises a virtual 3-D cylinder on which vertical sine wave grating as visual stimuli was presented. Speed of rotation and geometry of the cylinder as well as spatial frequency of the stimuli were controlled by the OptoMotry© software. The direction of the grating rotation (clockwise vs. counter-clockwise) was randomly chosen by the software and allowed for separate measurement of the eyes. The test animal moving unrestrained on the centered platform tracked the grating with reflexive head movements. Two independent observers assessed via live video image the tracking movement. The spatial frequency of the grating was randomly increased (staircase procedure) during the session until the animal no longer responded. The highest spatial frequency that the mouse could track was identified as the threshold by the software.
Statistics
The data are presented as the mean ± SD, and were compared using SigmaPlot 12.0 (Systat Software, Erkrath, Germany) and the Kruskal-Wallis One Way ANOVA with post-hoc analysis by the Tukey test. For comparison of two groups, the Student's t test was applied. Differences were considered statistically significant at P ≤ 0.05.
Results:
Differentiation of CD45 -BMSCs in vitro During coculture, the BMSCs changed their shape from a small, round appearance to a more elongated, epithelial-like morphology (Figure 1) . Thereby, we observed a cell survival rate of 30-40%, and 70.8 ± 4.4% of the GFP-positive cells displayed morphological changes. The CD45 -BMSCs showed no expression of the glia marker GFAP, the early neuronal marker βIIItubulin or the late neuronal marker MAP-2 after coculture with RPE. However, the pre-differentiated BMSCs were positively stained for the RPE markers RPE65 and bestrophin ( Figure 2 ).
Subretinal transplantation
BMSCs were harvested from the cocultures before transplantation and enriched by FACS using the FL1 fluorescence channel to separate GFP + cells. To avoid contamination by feeder cells that had taken up GFP, the sorting parameters were selected with appropriate controls (cultured feeder cells and GFP + /GFPbone marrow cells). The yield of sorted GFP + cells after coculture reached 44 ± 15% of the cell input. Approximately 60,000 pre-committed GFP + BMSCs were then transplanted into the subretinal space of mice with NaIO 3 -induced retinal degeneration with a success rate of 79% ( Figure 3A) . The transplanted cells could be identified by their GFP expression ( Figure 3B ).
To monitor transplant location and retinal development, FAF and SD-OCT images were taken at different time points (Figure 4 ). At BL, before NaIO 3 treatment and subretinal transplantation, retina imaging showed a normal fundus in the IR image and a homogeneous FAF signal on the posterior pole of the eye. The SD-OCT images, which were simultaneously taken, also showed normal retinal layering at that time point ( Figure 4A ). After transplantation, GFP + BMSCs could be visualized using FAF and SD-OCT. The transplants appeared as an inhomogeneous, focal hyperfluorescent FAF signal, and the simultaneously taken SD-OCT images showed a corresponding subretinal deposit in the area of the hyperfluorescent FAF signal at day 28 PT ( Figure 4B ).
Visual function
Functional measurements using the OKR revealed a significant decrease in visual acuity after treatment with NaIO 3 .
Measurements after transplantation of pre-differentiated BMSCs did not show significant functional rescue over time (Table 2 ). However, 33% of the animals showed improved visual acuity to a certain degree. The mean increase in visual acuity compared to the control eye was 24%.
Table 2. Visual acuity [c/°] after transplantation of pre-differentiated GFP + CD45bone marrow-derived stem cells (BMSC) in the right eye (OD) of a mouse with NaIO 3 -induced retinal degeneration (n = 15
Thickness measurements
To investigate possible rescue effects related to the subretinal BMSC transplantation, quantification of the retinal thickness using the OCT was conducted. The values were compared between sham-operated control (left eye -OS) and subretinal transplantation (right eye -OD) at different time points. The measured thickness after NaIO 3 showed significant thinning compared with the baseline in both groups. The retina of the transplanted eyes was further thinned compared with the control after 28 days. However, no statistically significant changes were found and the values after transplantation did not reach the values at baseline ( Figure 5 ).
In vivo differentiation
IHC was performed to visualize in vivo differentiation of the transplanted BMSCs, and the transplants could be identified in the subretinal space by their GFP expression. The cells were found mainly in the outer retina but also in the ganglion cell layer, indicating migration through the sensory retina. Transplanted BMSCs were frequently positive for the RPE marker RPE65 ( Figure 6 ). Thereby, the sensory retina above the differentiated BMSC appeared to be preserved ( Figure 6A ). Additionally, we found transplanted cells in proximity of remaining host RPE cells ( Figure 6B) . No positive staining for the glia marker GFAP or the neuronal lineage markers βIIItubulin and MAP-2 were found in the transplanted BMSCs. As damage to the RPE is a hallmark of AMD and one of the first pathophysiological events detectable replacement of the dysfunctional cells before irreversible atrophy of the foveal photoreceptors occurs was attempted [23, 24] . However, neither allogeneic nor autologous RPE transplantation has achieved morphological and/or functional rescue of the retina [3, 25] . One of the main hurdles for the successful clinical use of RPE transplantation is immune rejection despite the existence of ocular immune privilege [26] . Therefore, the use of BMSCs, which can be autologously harvested, has been pursued in recent years [27] , and the focus is on the small population of tissue-specific stem cells shown by Kucia et al. (2004) [10] . The hypothesis is that enriching for BMSCs and their partial differentiation in vitro prior to transplantation may provide a viable, effective alternative for regeneration by SC. To this end, we were able to trigger early human BMSCs (CD45 -CD38 + ) to morphologically and functionally progress along the RPE differentiation pathway in vitro [12] . Importantly, BMSCs can endogenously home to and incorporate into damaged RPE in vivo [13, 15] . These results point to the existence of SCs within the BM that are committed to the RPE lineage. There might be even an endogenous repair program to incorporate these cells into damaged RPE in vivo, which however cannot rescue the damaged structures efficiently.
Discussion
In this study, we used BMSCs that were pre-differentiated in vitro. Thereby, differentiation of the SCs towards the RPE lineage, characterized by expression of RPE markers, has been achieved after coculture with RPE. Our results indicate that the RPE cells provide the specific cues for a directed stem cell differentiation towards the RPE lineage. Soluble factors secreted by the feeder cells and/or the direct cell-cell contact may be involved. For both hypotheses, examples can be found in the literature [13, 16] . Possible mechanisms underlying the plasticity of BMSCs have been summarized by Catacchio et al. (2013) [6] . Therefore, the need for a final clarification of the details, especially the characterization of modulating factors, is a tedious nevertheless necessary task beyond the scope of this study.
Because of the described direct coculture, the pre-differentiated BMSCs have to be separated and enriched before transplantation. The performed FACS for GFP-positive cells yielded a relatively low amount of transplantable cells. Furthermore, the procedure generates mechanical and environmental stress for the BMSCs, which could be one explanation for the rather limited effect of the subretinal cell transplantation on the visual acuity. Monitoring the fate of the transplants is pivotal for the follow-up of location, integration, and development of the donor cells, and can also be used to quantify the success of this regenerative approach. We were able to locate the GFP + BMSCs using OCT during all investigated time points up to day 28 PT. The cells appeared as inhomogeneous, focal hyperfluorescent signals in the FAF images and as subretinal deposits in the corresponding area in the simultaneously taken SD-OCT images. During the investigated time period, the quantity of fluorescent signals appeared to decrease, even if the distribution area of the transplants did not show significant changes. Moreover, non-fluorescent areas within the expanse of the transplant appeared at later time points. This could either be due to a decrease in the number of surviving cells or a decrease in the GFP intensity over time.
Functional visual recovery after cell transplantation is always the main goal of regenerative approaches in retinal degeneration. Our results showed improvements in the visual acuity in individual animals of both groups. A modest (1-4%) to relatively high (10-198%) increase in the visual acuity of the transplanted eye was measured, but it did not reach baseline values. However, this increase in visual acuity after BMSC transplantation might be due to secretion of neurostimulating factors. In this regard, pigment epithelium-derived factor (PEDF) appears to be a possible candidate as it displays neurotrophic properties [28] . Further studies would be needed to identify and characterize substances responsible for this effect. On the other hand, the majority of animals did not show an increase but rather a further decrease of their visual function. This might be due to the already initiated apoptosis in the photoreceptors that follows the initial damage of the RPE by NaIO 3 [29] . The impact of the subretinal surgery on the visual function should also be taken into account.
The BMSCs were found in the subretinal space where they constituted structures resembling a restricted monolayer or cell bolus. Some cells also migrated into the sensory retina and were found in the inner nuclear layer or even the ganglion layer. However, integration of the subretinal transplanted BMSCs in the retinal structure was rather limited. Mechanical destruction of the retinal structures during microsurgery and thereby activation of Müller cells might also have played a role in inducing gliosis and preventing better incorporation of the SCs [30] .
Pre-committed BMSCs showed expression of the RPE marker RPE65 in vitro and then in the damaged subretinal space in vivo. None of the transplants showed positive staining for the neural markers. This indicates a RPE fate of the transplanted SCs indicating that specific cue can guide the differentiation path of a small population of BMSCs. However, too severe damage might prevent the stem cells from surviving in a deleterious environment and renders them unable to repair the damage.
Our data demonstrates that BMSCs were able to differentiate into RPE-like cells in vitro but did not repair the NaIO 3 -induced retinal degeneration in vivo. This could be because of the pharmacological model of retinal degeneration (NaIO 3 ) that we used, the cell type (BMSC) that was introduced, or the route of delivery (subretinal transplantation). Even without complete rescue of retinal structure and function by the transplanted BMSCs, this concept shows viable results. In view of the advantages of BMSCs, such as easy availability and the potential use of autologous cells in the human system, the approach should be investigated further. The experimental focus should be on better integration of the BMSCs, an increased number of pre-differentiated cells, and a more permissive microenvironment. Therefore, additional in vitro and in vivo experiments, including the utilization of human BMSCs, may bring more results regarding their potential use for retinal regeneration in degenerative diseases.
